Recall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study by Mortz, Charlotte G et al.
Syddansk Universitet
Recall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence
Cohort Study
Mørtz, Charlotte G; Andersen, Klaus Ejner; Bindslev-Jensen, Carsten
Published in:
 Acta Dermato-Venereologica
DOI:
10.2340/00015555-2128
Publication date:
2015
Document version
Publisher's PDF, also known as Version of record
Citation for pulished version (APA):
Mortz, C. G., Andersen, K. E., & Bindslev-Jensen, C. (2015). Recall Bias in Childhood Atopic Diseases Among
Adults in The Odense Adolescence Cohort Study.  Acta Dermato-Venereologica, 95(8), 968-72. DOI:
10.2340/00015555-2128
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 09. Sep. 2018
Acta Derm Venereol 95
CLINICAL REPORT
Acta Derm Venereol 2015; 95: 968–972
© 2015 The Authors. doi: 10.2340/00015555-2128
Journal Compilation © 2015 Acta Dermato-Venereologica. ISSN 0001-5555
Atopic dermatitis (AD) is a common disease in childhood 
and an important risk factor for the later development 
of other atopic diseases. Many publications on childhood 
AD use questionnaires based on information obtained in 
adulthood, which introduce the possibility of recall bias. 
In a prospective cohort study, recall bias was evaluated 
in 1,501 unselected schoolchildren (mean age 14 years) 
evaluated for the first time in 1995 with a standardized 
questionnaire combined with a clinical examination and 
repeated in 2010. The lifetime prevalence of AD was 
34.1% including data obtained both during school age 
and 15 years later, compared with 23.6% including data 
only from adulthood. The most important factors for re-
membering having had AD in childhood were: (i) long 
duration of dermatitis in childhood; (ii) adult hand ec-
zema; and (iii) concomitant atopic disease. Recall bias 
for childhood AD affected the results of logistic regres-
sion on adult hand eczema and is a significant problem 
in retrospective epidemiological questionnaire studies 
evaluating previous AD as a risk factor for development 
of other diseases. Key words: recall bias; atopic derma-
titis; asthma; allergic rhinitis; questionnaire; prospective 
studies.
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Atopic dermatitis (AD) is common, with a lifetime 
prevalence in the general population of approximately 
20–25% (1, 2). AD usually starts before the age of 2 
years, and many children outgrow the disease before 
starting school (3, 4). AD is considered one of the most 
important risk factors for developing adult hand eczema 
(5, 6). Since most studies of hand eczema in adults are 
cross-sectional or have a follow-up period during adult 
life, these studies assess risk factors in childhood based 
on questionnaires performed in adulthood. Self-report 
questionnaires asking adults about risk factors in child-
hood have the drawbacks of recall bias and the possibility 
of misclassifying the diagnosis of AD. Even a short pas-
sage of time can introduce a major recall bias, as people 
forget that they have had eczema (7). When asking adults 
about diseases occurring before school age the answers 
would therefore be even less accurate. 
The present study evaluated schoolchildren in the 8th 
grade (mean age 14 years) in 1995 using a standardized 
questionnaire answered by the children and their parents, 
combined with a clinical examination for eczema. The 
same procedure was repeated 15 years later in the same 
population (mean age 29 years, parents not involved) to 
evaluate the course of atopic diseases and recall bias.
MATERIAL AND METHODS
Population and study design
Phase One of The Odense Adolescence Cohort Study (TOACS) 
was conducted in 1995–96 as a cross-sectional study among 
1,501 8th grade schoolchildren in the Municipality of Odense, 
encompassing questionnaires, interviews and clinical examina-
tions, blood samples for immunoglobulin E (IgE) measurement 
and patch tests. Phase Two was conducted in 1996–97 as a 
case-control study in selected groups of schoolchildren (1). 
Phase Three is a 15-year follow-up study in the same popu-
lation (28–30 years of age). From the original cohort, 1,271 
subjects had provided consent to be contacted again and had 
provided their personal identification number for tracing. An 
invitation to the follow-up study was sent in 2010 together with 
a code to access an online questionnaire with 147 questions. 
If subjects did not answer after having been sent 2 reminders, 
the questionnaire was sent twice more as a paper version. 
Furthermore, participants were offered a clinical examina-
tion, measurement of specific IgE, skin-prick tests, pulmonary 
function test and patch tests. The examination and testing was 
performed in Odense, Copenhagen and Aarhus by the same 
investigator (CGM) who performed the Phase One and Two 
studies, assisted by 2 experienced dermatological nurses and 
a laboratory technician. Details of the follow-up study are pu-
blished elsewhere (5, 8, 9).
Phase Three questionnaire
The respondents completed the questionnaire with questions on 
AD, asthma, allergic rhino-conjunctivitis, hand eczema, urtica-
ria/angioedema and Type I and IV allergy. The questionnaire 
included the same questions as in Phase One, supplemented 
with new questions that included occupational aspects. In Phase 
One the schoolchildren and their parents were asked to complete 
the questionnaire together, while the young adults completed 
the questionnaire by themselves in Phase Three.
The lifetime prevalence of AD was defined by published 
questionnaire criteria based on several questions (Schultz Lar-
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sen criteria) (2) with a sensitivity of 88% and a specificity of 
89%. Furthermore, a single question on the lifetime prevalence 
of AD was included based on the Tuohilampi questionnaire: 
“Have you ever had childhood eczema (AD), an itchy rash 
(eczema) which has affected skin creases or folds (folds of 
elbows, behind the knees)?” (10, 11).
The lifetime prevalences of asthma and allergic rhinitis were 
evaluated using the Tuohilampi questionnaire/NOSQ-2002 
questionnaire, by answering the 2 questions: “Have you ever 
had asthma?” and “ Have you ever had ‘hay fever’ or other 
symptoms of nasal allergy (bouts of sneezing, ichy or running 
nose”) from e.g. pollen or animals?” (10, 11). A question on 
allergic eye symptoms was also included. 
All questions on atopic diseases were followed by the ques-
tion, “Was the diagnosis confirmed by a doctor?”
The lifetime prevalence of hand eczema was also determined 
by using the Tuohilampi questionnaire/NOSQ-2002 questionn-
aire (10, 11). The criteria for a history of hand eczema were 
eczema (rash) on the fingers, finger webs, palms or back of 
hands, which had appeared once and continued for at least 2 
weeks, or had appeared several times, or had been persistent.
Clinical examination
The 1-year period prevalence and point prevalence of AD were 
evaluated clinically according to the Hanifin & Rajka criteria 
(12) both in 1995 and 2010 by a dermatologist (CGM).
Ethics
The study was approved by the Regional Ethical Committee for 
Southern Denmark (S-VF-19950022).
Data handling and statistics
A total of 743 of the respondents answered the electronic ques-
tionnaire, while 156 answered the paper version. The responses 
from the paper version were subsequently entered into the 
database by the first author (CGM). All data from the clinical 
examination were entered twice. When differences were found, 
a comparison with raw input forms was made and corrections 
made accordingly. Statistical analysis was performed with 
STATA/SE 11.0 (Stata Corporation, TX, USA). 
The results are given as prevalence proportions and 95% con-
fidence interval (CI). Comparisons were made using χ2-based 
table analysis. Statistical significance was defined as p < 0.05.
RESULTS
A total of 1,206 subjects of the 1,271 (95%) from the 
original cohort were retrieved in Denmark through the 
national central person register; 4 had died, 1 person 
was missing, and 60 had emigrated. After 4 reminders 
the response rate for answering the questionnaire was 
74.6% (899/1,206), and 469/1,206 (38.9%) of the 
invited subjects (52.2% of those who responded by 
questionnaire) participated in the clinical examination. 
The 899 subjects answering the questionnaire in 2010 
were a representative part of the 1995 population, 
except that more women than men participated in the 
follow-up questionnaire and more with AD in child-
hood participated, as shown in Table I (5). 
Table II shows the lifetime prevalence of AD (Schultz 
Larsen criteria [2]) in the cohort of persons participating 
in both Phase One and Phase Three. The lifetime pre-
valence of AD was 24.0% in Phase One; 15 years later 
a similar lifetime prevalence was found (23.6%; 95% 
CI 20.9–26.6). However, on pooling those reporting 
AD in 1995 and/or 2010, the lifetime prevalence was 
34.1% (95% CI 31.0–37.2). 
In 1995, 215/897 fulfilled the criteria for AD. In 2010, 
however, only 121 of the original 215 subjects could 
identify themselves as having had childhood AD based 
on the same questions (Fig. 1), while 94 did not recall 
childhood AD (94/215; 43.7%, 95% CI 37.0–50.6). 
Among the 94 subjects not found in 2010, 56 had 
reported AD in 1995, with onset before the age of 5 
years (34 before 2 years of age, and 22 between 2 and 
5 years of age). In 30 of the 56 subjects, the dermatitis 
had cleared in less than 5 years. In 2010, 91 new cases 
were found (Fig. 1).
It was not possible to estimate a lifetime prevalence 
of AD based on clinical examination because the par-
ticipants were only examined twice during the study 
period (1995 and 2010). According to the Hanifin & 
Table I. Comparison of baseline characteristics (1995) between 
participants and non-participants in the questionnaire in the 
follow-up study (2010) (reproduced from ref. 5)
Baseline 
characteristics 1995
Participants 2010 
Prevalence, % (n)
Non-participants 2010 
Prevalence, % (n)
p-value
Sex
Female
Male
56.3 (506)
43.7 (393)
38.4 (207)
61.6 (332)
< 0.05
Present or past:
Atopic dermatitis 23.9 (215/899) 16.9 (91/539) < 0.003
Hand eczema 9.8 (88/899) 8.4 (45/539) 0.36
Allergic rhinitis 19.7 (177/899) 16.9 (91/539) 0.19
Asthma 12.0 (108/899) 11.3 (61/539) 0.69
Present:
Contact allergya 15.4 (120/778) 14.7 (54/368) 0.74
Positive specific 
IgEb
28.1 (171/609) 33.1 (86/260) 0.14
aIn Phase One 1,146 of the 1,438 participated in patch testing.
bIn Phase One 869 of the 1,438 participated in blood sample for IgE 
measurement.
Table II. Lifetime prevalence of atopic dermatitis (AD) (Schultz 
Larsen criteria (2)) in the 897 participating in both Phase One 
and Three questionnaires
Total population
n = 897a
% (n) [95% CI]
Women 
n = 505
% (n)
Men 
n = 392
% (n)
Ever AD
Phase One and/or Three 
(lifetime 0–29 years) 34.1 (306) [31.1–37.3] 38.0 (192) 29.1 (114)
Ever AD
Phase Three 
(lifetime 0–29 years) 23.6 (212) [20.9–26.6] 26.5 (134) 19.9 (78)
Ever AD 
Phase One 
(lifetime 0–14 years) 24.0 (215) 27.5 (139) 19.4 (76)
aIn total 899 subjects answered the questionnaire; however, only 897 
answered the questions on atopic dermatitis.
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Rajka criteria (12), the 1-year period prevalence of AD 
in 1995 was 6.7% (90/1,340) and the point prevalence 
3.6% (48/1340). In 2010 the 1-year period prevalence 
was 10.0% (47/469) and the point prevalence 6.2% 
(29/469). In 2010, 36/47 subjects with AD during the 
last year also had hand eczema (adults fulfilling the 
Hanifin & Rajka criteria for AD and having eczema on 
their hands). On the other hand, in 2010, 81/127 subjects 
with hand eczema during the last year had or had had 
AD. The association between AD and hand eczema, 
including different types of hand eczema, has been 
described previously (5). Almost all patients diagnosed 
as having AD (Hanifin & Rajka) by the dermatologist 
during the clinical examination were also identified by 
the questionnaire criteria (Schultz Larsen criteria) both 
in 1995 (85/90) and in 2010 (44/47). 
Using a single question on AD (Tuohilampi ques-
tionnaire) both in 1995 and 2010 a similar result was 
obtained (Table III) as using the published questionnaire 
criteria from Schultz Larsen (Table II). In 1995, 21.6% 
of subjects answered that they have/have had AD; in 
2010 this proportion had reduced to 18.8%. However, 
by pooling the data from 1995 and 2010, lifetime preva-
lence increased to 28.2% (95% CI 25.3–31.3) instead of 
18.8% (95% CI 16.3–21.6). In 1995, 194/897 answered 
“yes” to AD, and in 2010 only 110 of the 194 gave the 
same answer. Fifty of the 84 subjects giving a negative 
answer in 2010 had their debut of AD before the age of 
5 years (34 before the age of 2 years, 16 between the 
age of 2 and 5 years), and 32/50 had a duration of AD 
of less than 5 years. 
Compared with AD, the lifetime prevalence of asthma 
and allergic rhinitis was nearly identical, as evaluated 
by the questionnaire in 2010 compared with results eva-
luated by pooled data from 1995 and 2010 (Table III).
The same questions on hand eczema were also 
used both in 1995 and 2010. The lifetime prevalence 
calculated by pooling the data from 1995 and 2010 
was 23.0% (95% CI 20.3–25.9) compared with 18.2% 
(95% CI 15.7–20.9) using data reported only in 2010 
(data not shown). Hand eczema was found in 42.8% of 
subjects with AD.
When examining different factors (Table IV) in those 
subjects fulfilling the criteria for AD in both 1995 and 
2010 (Schultz Larsen criteria) compared with those 
not recalling AD in childhood, the most important 
factors for remembering AD were: (i) long duration 
of dermatitis in childhood; (ii) adult hand eczema; 
and (iii) concomitant atopic diseases. Middle to high 
educational level compared with no or short education 
did not affect recall. 
Of the 306 fulfilling the Schultz Larsen criteria for 
AD ever (1995 and/or 2010) 153 reported dermatitis 
during the last year in 2010 (50%), while 50% had 
outgrown the dermatitis. 
In the 153 with present AD, 45 reported a duration 
of AD of more than 20 years, 39 of 10–20 years, 30 of 
5–10 years, and 38 of less than 5 years (1 did not know). 
Looking at those with present AD and duration less 
than 10 years, it appears that 68/306 of subjects should 
have developed AD after the age of 18 years. However, 
including data from 1995, 29/68 already fulfilled the 
criteria for AD in adolescence. This mean that no more 
Table III. Lifetime prevalence of atopic dermatitis (AD), allergic 
rhinitis (AR) and asthma based on single questions (Tuohilampi 
questionnaire (10, 11)) in the 897 participating in both Phase One 
and Three questionnaires
Total population
 n = 897a
% (n) [95% CI]
Women 
n = 505
% (n)
Men
n = 392
% (n)
Ever AD
Phase One and/or Three 
(lifetime 0–29 years)
28.2 (253) 
[25.3–31.3] 31.5 (159) 24.0 (94)
Ever AD
Phase Three 
(lifetime 0–29 years)
18.8 (169)
[16.3–21.6] 22.0 (111) 14.8 (58)
Ever AD
Phase One 
(lifetime 0–14 years) 21.6 (194) 23.8 (120) 18.9 (74)
Ever AR
Phase One and/or Three 
(lifetime 0–29 years)
40.8 (366)
[37.6–44.1] 41.4 (209)  40.1 (157)
Ever AR
Phase Three 
(lifetime 0–29 years)
36.2 (325)
[33.1–39.5] 35.8 (181) 36.7 (144)
Ever AR
Phase One 
(lifetime 0–14 years) 19.7 (177) 20.2 (102) 19.1 (75)
Ever asthma
Phase One and/or Three 
(lifetime 0–29 years)
20.2 (181)
[17.6–23.0] 22.2 (112) 17.6 (69)
Ever asthma
Phase Three 
(lifetime 0–29 years)
17.3 (155)
[14.9–19.9] 18.8 (95) 15.3 (60)
Ever asthma
Phase One 
(lifetime 0–14 years) 12.0 (108) 10.9 (55) 13.5 (53)
aIn total 899 subjects answered the questionnaire; however, only 897 
answered the questions on atopic dermatitis, asthma and allergic rhinitis.
Fig. 1. Relationship betweeen atopic dermatitis in 1995 and 2010. Number 
of persons reporting atopic dermatitis ever in 1995 and when asked the same 
questionnaire again after 15 years in 2010. In totale 215 reported atopic 
dermatitis by questionnaire in 1995. Of these, 121 answered the same in 
2010 while 94 did not recall atopic dermatitis in childhood when asked 
again 15 years later. In 2010, 91 new cases were found.
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than 39/306 (12.7%) with AD could have developed AD 
after the age of 18 years. 
DISCUSSION 
Recall bias is a major problem in retrospective epide-
miological studies in adults, especially when including 
information about diseases in childhood. We found that 
a significant proportion of adults forgot that they had 
had childhood AD when they responded to a question-
naire at the age of 29 years compared with the answer 
given by themselves and their parents 15 years earlier. 
Those who remembered AD with a 15-year interval 
more often had a long duration of AD in childhood, 
hand eczema in adulthood and other atopic diseases. 
A study from Wisconsin showed that even a short 
passage of time can introduce major recall bias (7): 
in adults with AD, only 59% self-reported the disease 
correctly, and even parental recall of skin disease in 
children was only 70%. Furthermore, a Swedish study 
reported that 29% of subjects diagnosed with AD in 
the school health medical records could not recall that 
they had had the disease when asked 20–30 years later 
(13). Those remembering having AD in childhood had a 
higher prevalence of dermatitis after the age of 15 years 
and a higher prevalence of hand eczema, in agreement 
with our results. Cultural and educational factors may 
also affect the response to questionnaires on AD (14). 
However, educational level did not affect recall bias 
in this study. The severity of AD in childhood was 
not evaluated in the questionnaire and therefore not 
included in the analysis. It is possible that those with 
severe AD in childhood tend to remember having had 
AD in childhood compared with those with only mild 
dermatitis. Furthermore, in childhood the questionnaire 
was answered by the parent and the schoolchildren, 
while the questionnaire 15 years later was answered 
only by the young adults. This can affect recall, as 
parents remember diseases from early childhood that 
the 29-year-old adults did not recall. 
Compared with the results obtained for AD, patients 
tend to have less recall bias regarding asthma and al-
lergic rhinitis, perhaps due to the later debut of these 
diseases (in older childhood and adolescence). Further-
more, the occurrence of repeated attacks of asthma or 
rhinitis may increase memory and limit recall bias. 
In the TOACS cohort, 50% of the adults with AD 
had outgrown their eczema in 2010, and those with 
persistent AD as adults often had a long duration of 
AD. Less than 13% of those with adult AD had been 
first diagnosed after 18 years of age.
A questionnaire-based study always carries the risk 
of misclassification of diseases compared with the 
clinical diagnosis, which must be considered “the true 
diagnosis”. Much effort has been made to make vali-
dated questionnaires for the diagnosis AD (2, 15, 16). 
However, it can be difficult to make a questionnaire 
feasible for all age groups, e.g. infants, children, adol-
escents and adults. At the time of this study in 1994–95, 
the only validated questionnaire in Danish was chosen 
for evaluation of AD (2). The same questionnaire was 
used 15 years later, knowing that the questionnaire had 
not been validated in adults. Nearly all patients with a 
clinical diagnosis of AD present at the age of 14 years 
and 29 years were found by the questionnaire. As we did 
not perform periodic clinical examination of the cohort, 
the lifetime prevalence of AD cannot be estimated by 
clinical examination, and we are unable to determine 
if the questionnaire overestimated the prevalence of 
AD. In 1995 and 2010 a single question on AD was 
used in another part of the questionnaire, together with 
questions on asthma and allergic rhinitis, which gave a 
nearly identical estimation of AD as the questionnaire-
based criteria based on summation of 18 questions 
(Schultz Larsen criteria). In a recent study from Sweden 
it was shown that the answer to a single question on AD 
tends to overestimate the prevalence of AD (17). In the 
Swedish study, 71% of cases with AD identified in the 
school health medical system answered “yes” to having 
had AD (29% answered “no”), while 10% of controls 
answered “yes” to having had AD. The specificity was 
71% and the sensitivity 90%. The sensitivity was higher 
and the specificity was lower in a subgroup with current 
hand eczema. Patients without AD sometimes report 
childhood AD because they have had some eczema or 
other skin diseases that are misclassified as AD (e.g. 
Table IV. Different factors in relation to the group of adults remembering having had atopic dermatitis (AD) in childhood compared 
with those not recalling AD in childhood (Schultz Larsen criteria (2))
Remembering AD in childhood
% (n)
Do not recall AD in childhood
% (n)
p-value
Duration of AD > 10 years at 14 years of age 54.5 (66/121) 21.3 (20/94) < 0.001
Hand eczema during the last year as adulta 40.0 (48/120) 5.4 (5/93) < 0.001
Visit to a physician due to hand eczema as adulta 23.3 (28/120) 1.2 (1/93) < 0.001
Allergic rhinitis 64.5 (78/121) 42.6 (40/94) < 0.003
Asthma 38.8 (47/121) 21.3 (20/94) < 0.03
Middle–high educational level 52.9 (64/121) 52.1 (49/94) NS
aTwo did not answer the questions on hand eczema in 2010.
NS: not significant.
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allergic contact dermatitis, irritant contact dermatitis, 
seborrhoeic dermatitis or skin diseases such as psoriasis 
or fungal infection).
We found that a large proportion of young adults 
did not recall AD in childhood, either using a valida-
ted questionnaire with 18 questions on AD or a single 
question on AD. They did, however, recall asthma and 
allergic rhinitis. Studies on hand eczema in adults, often 
include questions on childhood AD when evaluating 
risk factors for adult hand eczema, and the magnitude 
of recall bias will influence the analysis for risk factors 
in such studies. In prospective follow-up studies risk 
factors from childhood can be evaluated in relation 
to the development of adult disease. However, if the 
study is retrospective, recall bias regarding factors 
from childhood can be presented and can affect risk 
assessment. Earlier we reported risk factors for adult 
hand eczema (5). We showed that childhood AD (AD 
diagnosed in 1995) is a risk factor for adult hand eczema 
in a logistic regression model with an odds ratio (OR) 
of 1.9 (5) (prospective follow-up study). However, 
if we used data on childhood AD obtained in 2010 
(retrospective design) in the same logistic regression 
model an OR of 4.1 was obtained (data not shown). 
This would have overestimated the role of AD in adult 
hand eczema, giving an OR of 4.1 instead of 1.9, due to 
recall bias in the retrospective design, and must be taken 
into account in future studies on adults that include a 
history of childhood AD. Furthermore, there is a need 
for improved and validated diagnostic criteria for AD 
that are useful for both children and adults. 
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